Report overview
Calcium channel blockers?CCBs? are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker. This report contains market size and forecasts of Calcium Channel Blocker in global, including the following market information:
Global Calcium Channel Blocker Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Calcium Channel Blocker Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Calcium Channel Blocker companies in 2022 (%)
The global Calcium Channel Blocker market was valued at US$ 79 million in 2022 and is projected to reach US$ 88 million by 2029, at a CAGR of 1.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
We surveyed the Calcium Channel Blocker manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Calcium Channel Blocker Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Calcium Channel Blocker Market Segment Percentages, by Type, 2022 (%)
Dihydropyridine
Diltiazem
Verapamil
Others
Global Calcium Channel Blocker Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Calcium Channel Blocker Market Segment Percentages, by Application, 2022 (%)
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Global Calcium Channel Blocker Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Calcium Channel Blocker Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Calcium Channel Blocker revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Calcium Channel Blocker revenues share in global market, 2022 (%)
Key companies Calcium Channel Blocker sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Calcium Channel Blocker sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Calcium Channel Blocker, market overview.
Chapter 2: Global Calcium Channel Blocker market size in revenue and volume.
Chapter 3: Detailed analysis of Calcium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Calcium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Calcium Channel Blocker capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
